This trial is active but is no longer accepting patients.
This research study is being done to learn more about multiple myeloma and if the study drug, GSK2857916, can improve multiple myeloma in patients who have already failed other treatments. We also would like to answer the following questions:
Some parts of this study are research which means they have not been tested yet.
Please note that GSK2857916 is not yet approved for use in people with multiple myeloma.
Yes. You will receive GSK2857916 in a vein over 30 minutes once every 3 weeks on Day 1 of each 21-day cycle.
The following criteria is provided for health care professionals.
There are no active centers to display for this trial. Please call us at (888) 828-2206 and we'll help answer any questions that you may have.